Table 1.
Characteristics of the 1,671 HIV-seropositive women from the Women’s Interagency HIV Study included in this analysis.
| At the baseline visit (n=1,671) |
For all visits (n=11,132) |
|
|---|---|---|
| Non-Adherence | ||
| Yes | 401 (24%) | 2718 (24%) |
| Age in years, mean (SD) | 40 (8) | 43 (8) |
| Race/ethnicity | ||
| White, non-Hispanic | 243 (15%) | 1816 (16%) |
| White, Hispanic | 174 (10%) | 889 (8%) |
| African-American, non-Hispanic | 896 (54%) | 5890 (53%) |
| African-American, Hispanic | 36 (2%) | 250 (2%) |
| Other | 322 (19%) | 2287 (21%) |
| Study Site | ||
| Bronx | 329 (19.7%) | 2215 (19.9%) |
| Brooklyn | 274 (16.4%) | 2137 (19.2%) |
| Washington, DC | 242 (14.5%) | 1500 (13.5%) |
| Los Angeles | 355 (21.2%) | 2163 (19.4%) |
| San Francisco | 244 (14.6%) | 1507 (13.5%) |
| Chicago | 227 (13.6%) | 1610 (14.5%) |
| Alcohol consumption | ||
| Abstainer | 958 (60%) | 6173 (58%) |
| Light (< 3 drinks/week) | 426 (26%) | 3211 (30%) |
| Moderate (3–13 drinks/week) | 173 (11%) | 985 (9%) |
| Heavier (≥ 14 drinks/week) | 53 (3%) | 252 (2%) |
| Drug Use Since Last Visit | ||
| No drugs | 1229 (76%) | 8411 (79%) |
| Marijuana only | 202 (12%) | 1209 (11%) |
| Use of heroin, cocaine, crack, methadone, or methamphetamine |
186 (11%) | 1013 (9%) |
| History of IDU | 335 (25%) | 2738 (28%) |
| Self-Perception of Central Fat | ||
| Any gain | 465 (28%) | 3172 (28%) |
| Any loss | 224 (13%) | 1789 (16%) |
| No change | 1061 (64%) | 6685 (60%) |
| Self-Perception of Peripheral Fat | ||
| Any gain | 419 (25%) | 2366 (21%) |
| Any loss | 328 (20%) | 2366 (21%) |
| No change | 924 (55%) | 6400 (58%) |
|
log10 HIV RNA at the previous visit, median (25th, 75th percentiles) |
2.60 (<1.90,3.84) | <1.90 (<1.90,3.44) |
| Any HAART Switch | ||
| Yes | 75 (16%) | 1057 (20%) |